CASE REPORT
|
doi:10.20944/preprints202201.0298.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Checkpoint inhibitors; Immune related adverse events; Cholestasis; Severe ductopenia; Vanishing bile duct syndrome
Online: 20 January 2022 (11:07:21 CET)